Roivant Sciences Ltd.
Ticker: 1635088
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.44-28.0% | 2.00+27.4% | 1.57-27.6% | 2.17-75.9% | 9.02+101.3% | 4.48-91.9% | 55.13+48.4% | 37.14 |
| Total Income | 1.44-28.0% | 2.00+27.4% | 1.57-27.6% | 2.17-75.9% | 9.02+101.3% | 4.48-91.9% | 55.13+48.4% | 37.14 |
| EXPENSES | ||||||||
| Expenditure | 367.44+7.7% | 341.15+10.8% | 307.80+7.2% | 287.09+1.3% | 283.40-18.1% | 346.19+97.5% | 175.32+103.5% | -5.0K |
| Tax | -3.96-117.0% | 23.33+233.3% | 7.00+50.5% | 4.65+118.2% | -25.57-305.2% | 12.46-1.6% | 12.66-50.7% | 25.67 |
| PROFIT | ||||||||
| PBT | -294.56-1.4% | -290.37-82.6% | -159.04+40.9% | -269.26-14.8% | -234.51-4.5% | -224.38-419.9% | 70.15-98.6% | 5.1K |
| Net Profit | -189.84+28.6% | -265.89-134.2% | -113.52+49.2% | -223.36-231.9% | 169.38+173.6% | -230.18-341.5% | 95.30-98.1% | 5.1K |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-200.00pp | 100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00%-200.00pp | 100.00%+200.00pp | -100.00%-200.00pp | 100.00% | 100.00% |
| EPS | -0.26+31.6% | -0.38-123.5% | -0.17+48.5% | -0.33-243.5% | 0.23+174.2% | -0.31-338.5% | 0.13-98.0% | 6.37 |
Corporate Events
Board MeetingROIV
202616Sep
Board Meeting
Annual General Meeting to elect two Class II directors (Dani…
SEC Filing ↗